Search Results - "Boult, J K R"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography by Li, J, Jamin, Y, Boult, J K R, Cummings, C, Waterton, J C, Ulloa, J, Sinkus, R, Bamber, J C, Robinson, S P

    Published in British journal of cancer (02-04-2014)
    “…Background: Magnetic resonance elastography (MRE) is an emerging imaging technique that affords non-invasive quantitative assessment and visualization of…”
    Get full text
    Journal Article
  2. 2

    Dichloroacetate induces autophagy in colorectal cancer cells and tumours by Lin, G, Hill, D K, Andrejeva, G, Boult, J K R, Troy, H, Fong, A-C L F W T, Orton, M R, Panek, R, Parkes, H G, Jafar, M, Koh, D-M, Robinson, S P, Judson, I R, Griffiths, J R, Leach, M O, Eykyn, T R, Chung, Y-L

    Published in British journal of cancer (15-07-2014)
    “…Background: Dichloroacetate (DCA) has been found to have antitumour properties. Methods: We investigated the cellular and metabolic responses to DCA treatment…”
    Get full text
    Journal Article
  3. 3

    Threshold for epileptiform activity is elevated in prion knockout mice by Ratté, S, Vreugdenhil, M, Boult, J.K.R, Patel, A, Asante, E.A, Collinge, J, Jefferys, J.G.R

    Published in Neuroscience (14-04-2011)
    “…Abstract Prion protein (PrP) is abundant in the nervous system, but its role remains uncertain. Prion diseases depend on an aggregation of the protein that is…”
    Get full text
    Journal Article
  4. 4

    Oesophageal adenocarcinoma is associated with a deregulation in the MYC MAX MAD network by Boult, J K R, Tanière, P, Hallissey, M T, Campbell, M J, Tselepis, C

    Published in British journal of cancer (17-06-2008)
    “…Oesophageal adenocarcinoma, which arises from an acquired columnar lesion, Barrett's metaplasia, is rising in incidence more rapidly than any other cancer in…”
    Get full text
    Journal Article
  5. 5

    SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma by Carreno, G, Boult, J K R, Apps, J, Gonzalez-Meljem, J M, Haston, S, Guiho, R, Stache, C, Danielson, L S, Koers, A, Smith, L M, Virasami, A, Panousopoulos, L, Buchfelder, M, Jacques, T S, Chesler, L, Robinson, S P, Martinez-Barbera, J P

    Published in Endocrine-related cancer (01-03-2019)
    “…Pharmacological inhibition of the sonic hedgehog (SHH) pathway can be beneficial against certain cancers but detrimental in others. Adamantinomatous…”
    Get full text
    Journal Article
  6. 6

    The role of tumour-derived iNOS in tumour progression and angiogenesis by Kostourou, V, Cartwright, J E, Johnstone, A P, Boult, J K R, Cullis, E R, Whitley, GStJ, Robinson, S P

    Published in British journal of cancer (04-01-2011)
    “…Background: Progressive tumour growth is dependent on the development of a functional tumour vasculature and highly regulated by growth factors and cytokines…”
    Get full text
    Journal Article
  7. 7

    The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function by Baker, L C J, Boult, J K R, Walker-Samuel, S, Chung, Y-L, Jamin, Y, Ashcroft, M, Robinson, S P

    Published in British journal of cancer (08-05-2012)
    “…Background: Hypoxia-inducible factor-1 (HIF-1) mediates the transcriptional response to hypoxic stress, promoting tumour progression and survival. This study…”
    Get full text
    Journal Article
  8. 8

    False-negative MRI biomarkers of tumour response to targeted cancer therapeutics by Boult, J K R, Jamin, Y, Jacobs, V, Gilmour, L D, Walker-Samuel, S, Halliday, J, Elvin, P, Ryan, A J, Waterton, J C, Robinson, S P

    Published in British journal of cancer (05-06-2012)
    “…Background: Non-invasive quantitative imaging biomarkers are essential for the evaluation of novel targeted therapeutics. Before deployment in clinical trials,…”
    Get full text
    Journal Article